ThinkEquity Downgrades Ceradyne (CRDN) to Hold
Tweet
Share
E-mailGet Alerts CRDN Hot Sheet
Price: $35.00 --0%
Rating Summary:
2 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 20 | New: 69
Rating Summary:
2 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 20 | New: 69
Join SI Premium – FREE
ThinkEquity downgraded Ceradyne (NASDAQ: CRDN) from Buy to Hold, price target lowered from $37 to $27.
For an analyst ratings summary and ratings history on Ceradyne click here. For more ratings news on Ceradyne click here.
Shares of Ceradyne closed at $26.57 yesterday.
For an analyst ratings summary and ratings history on Ceradyne click here. For more ratings news on Ceradyne click here.
Shares of Ceradyne closed at $26.57 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lantronix, Inc. (LTRX) PT Raised to $11 at Canaccord
- Barclays Downgrades HCA Healthcare Inc (HCA) to Equalweight
- Barclays Downgrades Universal Health Services (UHS) to Equalweight
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
ThinkEquitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
